Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273 https://www.medrxiv.org/content/10.1101/2023.07.13.23291675
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273 https://www.medrxiv.org/content/10.1101/2023.07.13.23291675